Pseudoephedrine News and Research

RSS

Save money wih generics

Today, more than ever, consumers can opt for generic equivalents of brand-name medications at substantial cost savings.

10 Dec 2008

Exposure to pseudoephedrine common among young children

Researchers from Boston University's Slone Epidemiology Center have found that exposure to pseudoephedrine, a decongestant found in many cough-and-cold and allergy medications, has been common among U.S. children, especially those under the age of two years who are at the highest risk for toxicity and for whom safe dosing recommendations are lacking.

1 Dec 2008

Barr announces agreements on Nasacort AQ, Allegra D-12 and Allegra patent challenges

Barr Pharmaceuticals, Inc. today announced that its subsidiary, Barr Laboratories, Inc. has entered into separate settlement agreements related to ongoing patent challenges for Nasacort AQ (triamcinolone acetonide) nasal spray, Allegra D-12 Hour (fexofenadine hydrochloride 60mg and pseudoephedrine hydrochloride 120mg) extended-release tablets, and Allegra (fexofenadine) 30mg, 60mg and 180mg tablets.

19 Nov 2008

Drug group warns about over-reacting to methamphetamine abuse

A group which represents illegal drug users in Australia is warning authorities about the danger of adopting an alarmist approach in dealing with methamphetamine abuse.

29 Apr 2008

FDA approves formulations of Zyrtec (cetirizine HCl) for nonprescription use

The U.S. Food and Drug Administration has approved tablet, chewable tablet, and syrup formulations of Zyrtec (cetirizine HCl) for nonprescription use.

21 Nov 2007

FDA approves new nonprescription allergy drug Zyrtec-D

The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.

13 Nov 2007

Right medications essential for allergy control

Choosing the right medications is essential to gaining control over symptoms as allergy season comes into full bloom, allergy specialists at UT Southwestern Medical Center warn.

10 May 2007

Brits over-react to threat of crystal meth

In order to prevent the illegal production of the highly addictive drug, crystal meth, authorities in Britain are considering making some cold medicines available on a prescription-only basis.

26 Apr 2007

Crystal meth the new drug pandemic

According to a U.N. narcotics watchdog the synthetic drug methamphetamine is a bigger problem in the United States and other countries than either heroin or cocaine.

1 Mar 2006

Over-the-counter decongestant as good as prescription drug in relieving hay fever symptoms

There is no significant difference between an over-the-counter decongestant and a prescription medication that costs almost four times as much in relieving hay fever symptoms, report researchers from the University of Chicago in the February issue of Archives of Otolaryngology - Head & Neck Surgery.

24 Feb 2006

Law to restrict cold medicines well on it's way

A bill that would limit access to common cold medicines containing pseudoephedrine, an ingredient that can be used to make the highly addictive drug methamphetamine, has been unanimously approved by the Senate judiciary committee.

29 Jul 2005

Antibiotics should not be prescribed to patients with the common cold

Antibiotics should not be prescribed to patients with the common cold because there is scant evidence they stop other infections, and the benefits do not outweigh the risks, according to a new systematic review of current evidence.

19 Jul 2005

America's largest retail pharmacy is moving all over the counter single ingredient pseudoephedrine products behind the counter

Pseudoephedrine is the key precursor ingredient that can be converted into the illegal drug methamphetamine. After careful review of numerous state legislative proposals and law enforcement bulletins, CVS made the decision to move these products behind the counter in all of its 5,400 stores across 36 states over the next sixty days.

27 Apr 2005

Meth abuse and curbs on cold medicines

As states and Congress rush to put common cold, cough and allergy drugs behind the pharmacy counter to curb illegal methamphetamine production, no one has asked consumers what they think about these restrictions -- until now. Harris Interactive asked nearly 3,000 consumers about these and related issues in a national survey commissioned by the National Consumers League (NCL) and Food Marketing Institute (FMI).

4 Apr 2005

High-rise homes have the highest levels of cockroach allergens

Roaches like to live high in the sky in places like Chicago, New York City and the Bronx, according to a recent study in the Journal of Allergy and Clinical Immunology. The study, conducted by an allergist affiliated with Children's Medical Center Dallas, found high-rise homes in Northeastern cities had the highest levels of cockroach allergens -- leading to a higher incidence of asthmatic episodes.

30 Mar 2005

Methamphetamine, biggest illegal drug menace in America

Ten Attorneys General and officials from 13 other states came together today to attack what they called the biggest illegal drug menace in America: the use and production of methamphetamine.

28 Feb 2005

Ranbaxy receives FDA approval to market Loratadine and Pseudoephedrine Sulfate extended release tablets

Ranbaxy Pharmaceuticals, a wholly-owned subsidiary of Ranbaxy Laboratories Limited of New Delhi, India, announced today that RLL has received approval from the U. S. Food and Drug Administration to manufacture and market Loratadine and Pseudoephedrine Sulfate Extended Release Tablets

26 Sep 2004